Black Rock Inc. Novan, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.41 - $1.4 $10,992 - $37,535	26,811 Added 8.87%	329,123 $141,000
Q1 2023 May 12, 2023	BUY	$1.05 - $2.04 $1,207 - $2,346	1,150 Added 0.38%	302,312 $393,000
Q4 2022 Feb 13, 2023	BUY	$0.82 - $1.48 $483 - $873	590 Added 0.2%	301,162 $439,000
Q3 2022 Nov 14, 2022	SELL	$1.76 - $3.03 $10,076 - $17,346	-5,725 Reduced 1.87%	300,572 $562,000
Q2 2022 Aug 12, 2022	BUY	$2.29 - $3.86 $7,463 - $12,579	3,259 Added 1.08%	306,297 $714,000

Q1 2022 May 12, 2022	SELL	$2.95 - $4.41 $277 - $414	-94 Reduced 0.03%	303,038 $1.19 Million
Q4 2021 Feb 10, 2022	BUY	$4.03 - $8.15 $463 - $937	115 Added 0.04%	303,132 $1.26 Million
Q3 2021 Nov 09, 2021	SELL	$7.48 - $10.17 $833,578 - $1.13 Million	-111,441 Reduced 26.89%	303,017 $2.47 Million
Q2 2021 Aug 11, 2021	BUY	$7.8 - $17.35 $3.23 Million - $7.19 Million	414,458 New	414,458 $4.17 Million

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.